TDSPHARM CEO Cheoljun Kim Increases Stake by 750 Shares via Open Market Purchase, Ownership Rises to 45.93%

TDSPHARM CEO Cheoljun Kim acquired an additional 750 common shares through an open market purchase on June 15, 2026.
This purchase increased his total holdings to 2,539,847 shares, raising his ownership from 45.91% to 45.93% based on total outstanding shares of 5,530,000.
The purchase price was 11,656.52 KRW per share, reflecting the market price at the time of the transaction.
While insider buying is often viewed as a positive signal, the small scale of this transaction suggests no significant immediate impact on stock price.
[AI Summary]The CEO's minor open market purchase demonstrates management confidence but due to the already high stake and negligible increase, shareholder value sees no material change.